Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ACTU NASDAQ:ATHE NASDAQ:CRBU NASDAQ:FTLF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTUActuate Therapeutics$8.72+1.3%$7.26$5.47▼$11.99$178.62MN/A51,757 shs86,042 shsATHEAlterity Therapeutics$4.74-8.2%$4.89$1.00▼$7.00$44.96M0.414,424 shs10,500 shsCRBUCaribou Biosciences$1.85-2.1%$1.84$0.66▼$3.00$176M2.54840,388 shs543,733 shsFTLFFitLife Brands$18.43+7.3%$14.92$9.83▼$18.96$161.34M0.6514,629 shs10,803 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTUActuate Therapeutics+1.28%+6.08%+19.29%-2.68%+6.47%ATHEAlterity Therapeutics-6.61%-5.68%-12.31%+0.11%+240.65%CRBUCaribou Biosciences-2.12%-4.64%-9.31%+46.83%-2.63%FTLFFitLife Brands+7.28%-1.34%+19.29%+28.79%+11.09%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeACTUActuate Therapeutics$8.72+1.3%$7.26$5.47▼$11.99$178.62MN/A51,757 shs86,042 shsATHEAlterity Therapeutics$4.74-8.2%$4.89$1.00▼$7.00$44.96M0.414,424 shs10,500 shsCRBUCaribou Biosciences$1.85-2.1%$1.84$0.66▼$3.00$176M2.54840,388 shs543,733 shsFTLFFitLife Brands$18.43+7.3%$14.92$9.83▼$18.96$161.34M0.6514,629 shs10,803 shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceACTUActuate Therapeutics+1.28%+6.08%+19.29%-2.68%+6.47%ATHEAlterity Therapeutics-6.61%-5.68%-12.31%+0.11%+240.65%CRBUCaribou Biosciences-2.12%-4.64%-9.31%+46.83%-2.63%FTLFFitLife Brands+7.28%-1.34%+19.29%+28.79%+11.09%Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookACTUActuate TherapeuticsN/AN/AN/AN/A$0.01 per shareN/AATHEAlterity TherapeuticsN/AN/AN/AN/A$1.04 per shareN/ACRBUCaribou Biosciences$9.99M17.24N/AN/A$2.79 per share0.66FTLFFitLife Brands$64.47M2.68$1.09 per share16.96$3.93 per share4.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateACTUActuate Therapeutics-$27.28MN/A0.00∞N/AN/AN/A-281.83%N/AATHEAlterity Therapeutics-$12.54MN/A0.00∞N/AN/AN/AN/AN/ACRBUCaribou Biosciences-$149.10M-$1.78N/AN/AN/A-1,800.93%-62.35%-49.65%11/5/2025 (Estimated)FTLFFitLife Brands$8.98M$0.8421.9416.75N/A12.63%21.70%13.45%N/ALatest ATHE, ACTU, FTLF, and CRBU EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025ACTUActuate Therapeutics-$0.19-$0.30-$0.11-$0.30N/AN/A8/14/2025Q2 2025FTLFFitLife Brands$0.18$0.18N/A$0.18$16.17 million$16.13 million8/12/2025Q2 2025CRBUCaribou Biosciences-$0.40-$0.35+$0.05-$0.58$1.64 million$2.67 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthACTUActuate TherapeuticsN/AN/AN/AN/AN/AATHEAlterity TherapeuticsN/AN/AN/AN/AN/ACRBUCaribou BiosciencesN/AN/AN/AN/AN/AFTLFFitLife BrandsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioACTUActuate TherapeuticsN/A0.730.73ATHEAlterity TherapeuticsN/A12.98N/ACRBUCaribou BiosciencesN/A6.666.66FTLFFitLife Brands0.151.710.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipACTUActuate TherapeuticsN/AATHEAlterity Therapeutics2.14%CRBUCaribou Biosciences77.51%FTLFFitLife Brands2.32%Insider OwnershipCompanyInsider OwnershipACTUActuate Therapeutics69.34%ATHEAlterity Therapeutics38.80%CRBUCaribou Biosciences8.28%FTLFFitLife Brands61.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableACTUActuate Therapeutics1020.75 million6.36 millionN/AATHEAlterity Therapeutics108.87 million5.43 millionNot OptionableCRBUCaribou Biosciences10093.12 million85.41 millionOptionableFTLFFitLife Brands209.39 million3.63 millionNot OptionableATHE, ACTU, FTLF, and CRBU HeadlinesRecent News About These CompaniesMink Brook Asset Management LLC Has $929,000 Stake in FitLife Brands Inc. $FTLFAugust 26, 2025 | marketbeat.comFitLife Brands Updates Corporate Presentation StrategyAugust 20, 2025 | msn.comRoth Capital Forecasts Strong Price Appreciation for FitLife Brands (NASDAQ:FTLF) StockAugust 17, 2025 | marketbeat.comFitLife Brands (NASDAQ:FTLF) Issues Quarterly Earnings Results, Meets EstimatesAugust 16, 2025 | marketbeat.comFitLife Brands, Inc. (NASDAQ:FTLF) Q2 2025 Earnings Call TranscriptAugust 16, 2025 | msn.comFitLife Brands price target raised to $25 from $20 at Roth CapitalAugust 15, 2025 | msn.comFitLife Brands Reports Q2 2025 Financial ResultsAugust 15, 2025 | msn.comFitLife Brands, Inc. (FTLF) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comFitLife Brands Holds 2025 Annual Stockholders MeetingAugust 14, 2025 | msn.comFitLife Brands Reports 5 Percent Q2 DropAugust 14, 2025 | aol.comAFitLife Brands reports Q2 EPS 18c vs. 27c last yearAugust 14, 2025 | msn.comA Peek at FitLife Brands's Future EarningsAugust 13, 2025 | benzinga.comAnalysts Offer Insights on Consumer Goods Companies: Church & Dwight (CHD) and FitLife Brands (FTLF)August 11, 2025 | theglobeandmail.comFitLife Brands Closes Acquisition of Irwin NaturalsAugust 11, 2025 | globenewswire.comRoth Capital Estimates FitLife Brands Q2 EarningsAugust 9, 2025 | marketbeat.comRoth Capital Reduces Earnings Estimates for FitLife BrandsAugust 8, 2025 | marketbeat.comFitLife Brands (NASDAQ:FTLF) Trading 18.4% Higher - Here's WhyAugust 6, 2025 | marketbeat.comFitLife Brands to Acquire Irwin NaturalsAugust 5, 2025 | globenewswire.comFitLife Brands Announces Second Quarter Earnings CallAugust 1, 2025 | globenewswire.comFitLife Brands: Premium Valuation Faces Uncertain Rebound, A Hold For NowJuly 24, 2025 | seekingalpha.comFitLife Brands Holds on to Analyst Confidence Amid Mixed Sales and Online StrengthJuly 24, 2025 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 20253 Robotics Stocks at the Heart of the Robotics RevolutionBy Chris Markoch | August 21, 2025Vertical Aerospace: An Analyst's Roadmap to a Potential Re-RatingBy Jeffrey Neal Johnson | August 27, 2025Realty Income Rallies Post-Earnings Miss—Here’s What Drove ItBy Gabriel Osorio-Mazilli | August 7, 2025ATHE, ACTU, FTLF, and CRBU Company DescriptionsActuate Therapeutics NASDAQ:ACTU$8.72 +0.11 (+1.28%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$8.65 -0.07 (-0.80%) As of 09/4/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Actuate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of cancers. The company's lead product candidate is Elraglusib Injection, a novel glycogen synthase kinase-3 inhibitor to treat metastatic pancreatic ductal adenocarcinoma. It also develops Elraglusib for the treatment of Ewing sarcoma, metastatic melanoma, and colorectal cancer. The company was formerly known as Apotheca Therapeutics, Inc. and changed its name to Actuate Therapeutics, Inc. in October 2015. The company was incorporated in 2015 and is based in Fort Worth, Texas.Alterity Therapeutics NASDAQ:ATHE$4.74 -0.43 (-8.24%) Closing price 09/3/2025 07:24 PM EasternExtended Trading$4.74 0.00 (0.00%) As of 09/3/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that is in Phase I clinical trial for the treatment of Parkinson's disease. It is also developing ATH434-201, which is in Phase II clinical trial to treat multiple system atrophy early stage; ATH434-202 that is in Phase II clinical trial to treat multiple system atrophy advance; and PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.Caribou Biosciences NASDAQ:CRBU$1.85 -0.04 (-2.12%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$1.86 +0.01 (+0.49%) As of 05:43 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. Its lead product candidate is CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma. The company also develops CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.FitLife Brands NASDAQ:FTLF$18.43 +1.25 (+7.28%) Closing price 09/4/2025 04:00 PM EasternExtended Trading$18.39 -0.04 (-0.24%) As of 09/4/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Insider Selling: Risk Signal or Normal Activity? Buy the Dip? GitLab’s Bullish Case Outweighs the Bears Affirm Crushes Earnings Expectations, Turns Bears into Believers Gold’s Explosive Rally: GDX ETF May Be the Fast Track to Profits Dollar Tree Plunges Into Buy-Zone: A Robust Rebound Is Expected Zscaler Shares Can Hit a Fresh High Before Year-End Why Qualcomm Is Outperforming NVIDIA After Months of Lagging Alphabet Stock Surges After Dodging Harsh Antitrust Remedies Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
